being evaluated in Arizona by Dr. Von Hoff, he is the same doctor that evaluated Azixa, world renowned and respected in oncology development. 2nd phase 1 being initiated in latter half of 07. Safety profile good, advanced to 2nd dosing cohort.
Apoptosis is the key to future oncology development IMHO